| Yazarlar |
Dr. Öğr. Üyesi Lütfi TUTAR
Kahramanmaraş Sütçü İmam Üniversitesi, Türkiye |
Esen Tutar
|
|
Yusuf Tutar
Cumhuriyet Üniversitesi, Türkiye |
| Özet |
| MiRNAs are a family of small, endogenous, and evolutionarily conserved non-coding ribonucleic acids that have been involved in the regulation of several essential, cellular, and functional processes. MicroRNAs are known to play key roles in all types of cancer and function as oncogenes (oncomirs) or tumour-suppressors in up-regulation or down-regulation processes respectively. MiRNAs have potential power to be examined as prognostic and diagnostic biomarkers. Modulating miRNAs, based on two major approaches (miRNA mimics and miRNA antagonists), is used for clinical development of therapeutic miRNAs. This review emphasizes the latest discovery in the field of miRNA research involved in cancer, biomarkers, and therapeutics. |
| Anahtar Kelimeler |
| Biomarkers, cancer, microRNAs, therapeutics |
| Makale Türü | Özgün Makale |
| Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale |
| Dergi Adı | Current Pharmaceutical Biotechnology |
| Dergi ISSN | 1389-2010 |
| Dergi Tarandığı Indeksler | SCI-Expanded |
| Makale Dili | İngilizce |
| Basım Tarihi | 08-2014 |
| Cilt No | 15 |
| Sayı | 5 |
| Sayfalar | 430 / 437 |
| Doi Numarası | 10.2174/1389201015666140519095304 |
| Makale Linki | http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1389-2010&volume=15&issue=5&spage=430 |
| Atıf Sayıları | |
| Google Scholar | 95 |
